CTAC NV (CTAC.AS) Fundamental Analysis & Valuation

AMS:CTAC • NL0000345577

2.94 EUR
-0.06 (-2%)
Last: Mar 12, 2026, 07:00 PM

This CTAC.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Overall CTAC gets a fundamental rating of 5 out of 10. We evaluated CTAC against 75 industry peers in the IT Services industry. CTAC has an average financial health and profitability rating. CTAC has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. CTAC.AS Profitability Analysis

1.1 Basic Checks

  • In the past year CTAC was profitable.
  • In the past year CTAC had a positive cash flow from operations.
  • Each year in the past 5 years CTAC has been profitable.
  • Each year in the past 5 years CTAC had a positive operating cash flow.
CTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFCTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1.2 Ratios

  • CTAC's Return On Assets of 8.12% is amongst the best of the industry. CTAC outperforms 84.00% of its industry peers.
  • CTAC's Return On Equity of 18.91% is fine compared to the rest of the industry. CTAC outperforms 77.33% of its industry peers.
  • CTAC has a Return On Invested Capital (6.91%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CTAC is below the industry average of 11.13%.
Industry RankSector Rank
ROA 8.12%
ROE 18.91%
ROIC 6.91%
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.63%
ROE(5y)12.49%
ROIC(3y)7.76%
ROIC(5y)7.73%
CTAC.AS Yearly ROA, ROE, ROICCTAC.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • CTAC's Profit Margin of 3.10% is in line compared to the rest of the industry. CTAC outperforms 52.00% of its industry peers.
  • CTAC's Profit Margin has improved in the last couple of years.
  • CTAC has a Operating Margin of 2.97%. This is in the lower half of the industry: CTAC underperforms 65.33% of its industry peers.
  • CTAC's Operating Margin has improved in the last couple of years.
  • The Gross Margin of CTAC (37.21%) is worse than 68.00% of its industry peers.
  • In the last couple of years the Gross Margin of CTAC has declined.
Industry RankSector Rank
OM 2.97%
PM (TTM) 3.1%
GM 37.21%
OM growth 3Y-9.71%
OM growth 5Y12.14%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
CTAC.AS Yearly Profit, Operating, Gross MarginsCTAC.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. CTAC.AS Health Analysis

2.1 Basic Checks

  • CTAC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for CTAC remains at a similar level compared to 1 year ago.
  • CTAC has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CTAC has an improved debt to assets ratio.
CTAC.AS Yearly Shares OutstandingCTAC.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CTAC.AS Yearly Total Debt VS Total AssetsCTAC.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • CTAC has an Altman-Z score of 3.78. This indicates that CTAC is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.78, CTAC is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • CTAC has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.37, CTAC is in line with its industry, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z 3.78
ROIC/WACC1.07
WACC6.45%
CTAC.AS Yearly LT Debt VS Equity VS FCFCTAC.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

  • CTAC has a Current Ratio of 1.00. This is a normal value and indicates that CTAC is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of CTAC (1.00) is worse than 65.33% of its industry peers.
  • CTAC has a Quick Ratio of 1.00. This is a normal value and indicates that CTAC is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.00, CTAC is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
CTAC.AS Yearly Current Assets VS Current LiabilitesCTAC.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

3. CTAC.AS Growth Analysis

3.1 Past

  • CTAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 308.73%, which is quite impressive.
  • CTAC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.20% yearly.
  • The Revenue has decreased by -2.28% in the past year.
  • The Revenue has been growing by 8.74% on average over the past years. This is quite good.
EPS 1Y (TTM)308.73%
EPS 3Y-5.51%
EPS 5Y24.2%
EPS Q2Q%N/A
Revenue 1Y (TTM)-2.28%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%3.33%

3.2 Future

  • Based on estimates for the next years, CTAC will show a small growth in Earnings Per Share. The EPS will grow by 3.39% on average per year.
  • The Revenue is expected to grow by 7.12% on average over the next years.
EPS Next Y14.29%
EPS Next 2Y15.18%
EPS Next 3Y9.88%
EPS Next 5Y3.39%
Revenue Next Year2.42%
Revenue Next 2Y3.37%
Revenue Next 3Y3.63%
Revenue Next 5Y7.12%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CTAC.AS Yearly Revenue VS EstimatesCTAC.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
CTAC.AS Yearly EPS VS EstimatesCTAC.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.1 0.2 0.3

6

4. CTAC.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.50 indicates a reasonable valuation of CTAC.
  • Compared to the rest of the industry, the Price/Earnings ratio of CTAC indicates a rather cheap valuation: CTAC is cheaper than 89.33% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of CTAC to the average of the S&P500 Index (25.71), we can say CTAC is valued rather cheaply.
  • The Price/Forward Earnings ratio is 8.87, which indicates a very decent valuation of CTAC.
  • Based on the Price/Forward Earnings ratio, CTAC is valued cheaply inside the industry as 82.67% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 23.82. CTAC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.5
Fwd PE 8.87
CTAC.AS Price Earnings VS Forward Price EarningsCTAC.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CTAC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CTAC is cheaper than 88.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.22
CTAC.AS Per share dataCTAC.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.74
PEG (5Y)0.43
EPS Next 2Y15.18%
EPS Next 3Y9.88%

6

5. CTAC.AS Dividend Analysis

5.1 Amount

  • CTAC has a Yearly Dividend Yield of 3.75%.
  • CTAC's Dividend Yield is a higher than the industry average which is at 2.56.
  • Compared to an average S&P500 Dividend Yield of 1.82, CTAC pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.75%

5.2 History

  • On average, the dividend of CTAC grows each year by 17.13%, which is quite nice.
Dividend Growth(5Y)17.13%
Div Incr Years0
Div Non Decr Years1
CTAC.AS Yearly Dividends per shareCTAC.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

  • 26.79% of the earnings are spent on dividend by CTAC. This is a low number and sustainable payout ratio.
  • CTAC's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP26.79%
EPS Next 2Y15.18%
EPS Next 3Y9.88%
CTAC.AS Yearly Income VS Free CF VS DividendCTAC.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CTAC.AS Dividend Payout.CTAC.AS Dividend Payout, showing the Payout Ratio.CTAC.AS Dividend Payout.PayoutRetained Earnings

CTAC.AS Fundamentals: All Metrics, Ratios and Statistics

CTAC NV

AMS:CTAC (3/12/2026, 7:00:00 PM)

2.94

-0.06 (-2%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners5.23%
Inst Owner ChangeN/A
Ins Owners22.27%
Ins Owner ChangeN/A
Market Cap41.60M
Revenue(TTM)188.22M
Net Income(TTM)5.81M
Analysts80
Price Target2.87 (-2.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.75%
Yearly Dividend0.11
Dividend Growth(5Y)17.13%
DP26.79%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-22.22%
EPS NY rev (3m)-22.22%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.51%
Revenue NY rev (3m)-4.51%
Valuation
Industry RankSector Rank
PE 10.5
Fwd PE 8.87
P/S 0.22
P/FCF N/A
P/OCF 20.15
P/B 1.35
P/tB 9.75
EV/EBITDA 4.22
EPS(TTM)0.28
EY9.52%
EPS(NY)0.33
Fwd EY11.28%
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)0.15
OCFY4.96%
SpS13.23
BVpS2.17
TBVpS0.3
PEG (NY)0.74
PEG (5Y)0.43
Graham Number3.7
Profitability
Industry RankSector Rank
ROA 8.12%
ROE 18.91%
ROCE 14.87%
ROIC 6.91%
ROICexc 7.31%
ROICexgc 20.83%
OM 2.97%
PM (TTM) 3.1%
GM 37.21%
FCFM N/A
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.63%
ROE(5y)12.49%
ROIC(3y)7.76%
ROIC(5y)7.73%
ROICexc(3y)9.86%
ROICexc(5y)10.11%
ROICexgc(3y)93.05%
ROICexgc(5y)116.82%
ROCE(3y)14.76%
ROCE(5y)14.73%
ROICexgc growth 3Y-10.84%
ROICexgc growth 5Y39.25%
ROICexc growth 3Y-2.56%
ROICexc growth 5Y15.11%
OM growth 3Y-9.71%
OM growth 5Y12.14%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
F-Score6
Asset Turnover2.62
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA 1.03
Cap/Depr 69.48%
Cap/Sales 1.99%
Interest Coverage 14.1
Cash Conversion 18.91%
Profit Quality N/A
Current Ratio 1
Quick Ratio 1
Altman-Z 3.78
F-Score6
WACC6.45%
ROIC/WACC1.07
Cap/Depr(3y)40.73%
Cap/Depr(5y)30.86%
Cap/Sales(3y)1.72%
Cap/Sales(5y)1.4%
Profit Quality(3y)401.58%
Profit Quality(5y)373.89%
High Growth Momentum
Growth
EPS 1Y (TTM)308.73%
EPS 3Y-5.51%
EPS 5Y24.2%
EPS Q2Q%N/A
EPS Next Y14.29%
EPS Next 2Y15.18%
EPS Next 3Y9.88%
EPS Next 5Y3.39%
Revenue 1Y (TTM)-2.28%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%3.33%
Revenue Next Year2.42%
Revenue Next 2Y3.37%
Revenue Next 3Y3.63%
Revenue Next 5Y7.12%
EBIT growth 1Y12.01%
EBIT growth 3Y-4.9%
EBIT growth 5Y21.94%
EBIT Next Year46.67%
EBIT Next 3Y16.96%
EBIT Next 5Y12.47%
FCF growth 1Y-117.49%
FCF growth 3Y-7.01%
FCF growth 5Y0.39%
OCF growth 1Y-81.98%
OCF growth 3Y2.52%
OCF growth 5Y4.91%

CTAC NV / CTAC.AS FAQ

What is the fundamental rating for CTAC stock?

ChartMill assigns a fundamental rating of 5 / 10 to CTAC.AS.


Can you provide the valuation status for CTAC NV?

ChartMill assigns a valuation rating of 6 / 10 to CTAC NV (CTAC.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for CTAC NV?

CTAC NV (CTAC.AS) has a profitability rating of 5 / 10.


What is the financial health of CTAC NV (CTAC.AS) stock?

The financial health rating of CTAC NV (CTAC.AS) is 4 / 10.


Can you provide the dividend sustainability for CTAC stock?

The dividend rating of CTAC NV (CTAC.AS) is 6 / 10 and the dividend payout ratio is 26.79%.